List of Flex Databases CTMS Customers
Prague, 170 00,
Czech Republic
Since 2010, our global team of researchers has been studying Flex Databases CTMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Flex Databases CTMS for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Flex Databases CTMS for Clinical Trial Management include: Bionical Emas, a United Kingdom based Life Sciences organisation with 243 employees and revenues of $53.0 million, Fgk Clinical Research, a Germany based Life Sciences organisation with 170 employees and revenues of $30.0 million, Solti Spain, a Spain based Life Sciences organisation with 60 employees and revenues of $3.0 million and many others.
Contact us if you need a completed and verified list of companies using Flex Databases CTMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Flex Databases CTMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bionical Emas | Life Sciences | 243 | $53M | United Kingdom | Flex Databases | Flex Databases CTMS | Clinical Trial Management | 2020 | n/a |
In 2020 Bionical Emas implemented Flex Databases CTMS. The Clinical Trial Management deployment served as a baseline CTMS to accelerate study and site management, site payments and reporting within the company's clinical operations.
Flex Databases CTMS was configured to centralize study and site management workflows, automate site payments processing and standardize reporting, using a validated, quick-to-deploy architecture. The implementation included validated EDC integrations for enrollment and payments, and delivered real-time operational metrics to support trial oversight.
The deployment's operational scope targeted clinical operations across the United Kingdom and EU, with primary governance anchored in the United Kingdom. Process changes focused on reducing manual tracking and instituting validated data flows between EDC and CTMS to support enrollment, payments and reporting during study execution.
|
|
|
Fgk Clinical Research | Life Sciences | 170 | $30M | Germany | Flex Databases | Flex Databases CTMS | Clinical Trial Management | 2021 | n/a |
In 2021, FGK Clinical Research implemented Flex Databases CTMS. The deployment targeted Clinical Trial Management within FGK's clinical operations across Europe and Germany, with the stated objective to standardize and simplify trial management across sponsors and study phases.
The implementation encompassed Flex Databases CTMS alongside companion eTMF capabilities to centralize study documentation and monitoring workflows. Configuration prioritized site monitoring support including offline CRA access, investigator payment tracking to manage payments and financial records, and study and site-level tracking to harmonize operational processes across phases.
Rollout was scoped to FGK's European operations in the clinical operations function, accompanied by process standardization and updated monitoring and payment workflows to enforce consistency and quality. The program focused on improving operational consistency, site monitoring effectiveness and investigator payment tracking, and FGK reported increased cost-effectiveness and quality across its European operations.
|
|
|
Solti Spain | Life Sciences | 60 | $3M | Spain | Flex Databases | Flex Databases CTMS | Clinical Trial Management | 2022 | n/a |
In 2022, Solti Spain selected Flex Databases CTMS to centralize monitoring, reporting and site management for multi-hospital breast cancer studies conducted across Spain. Selection occurred late 2022, deployment activities began in March 2023, and migration and go-live were completed in March 2024, establishing a formal rollout timeline from selection to operational use.
The deployment implemented Flex Databases CTMS as the central Clinical Trial Management system, consolidating site management, monitoring workflows, and reporting capabilities across participating hospitals. The implementation targeted clinical operations and standardized monitoring and reporting processes, with configuration of study-level access controls, site tracking, and centralized reporting to support cross-hospital coordination. Governance changes aligned workflows and data capture standards across sites, and the completed migration improved cross-hospital KPIs and monitoring workflows for SOLTI study teams in Spain.
|
Buyer Intent: Companies Evaluating Flex Databases CTMS
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||